Journal of Clinical Epidemiology
Volume 53, Issue 11 , Pages 1164-1169, November 2000

Primary hyperparathyroidism detected in a health screening:

The Tromsø Study

  • Rolf Jorde

      Affiliations

    • Department of Internal Medicine, University Hospital of Tromsø, 9038 Tromsø, Norway
    • Centre for Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, University of Newcastle, Newcastle, Australia
    • Corresponding Author InformationCorresponding author. Tel.: 47 776 26000; fax: 47 776 26863.(R. Jorde)
  • ,
  • Kaare H Bønaa

      Affiliations

    • Institute of Community Medicine, University Hospital of Tromsø, Tromsø, Norway
  • ,
  • Johan Sundsfjord

      Affiliations

    • Department of Clinical Chemistry, University Hospital of Tromsø, Tromsø, Norway

Received 20 January 1999; received in revised form 29 February 2000; accepted 4 March 2000.

Abstract 

Serum calcium was measured in 12,339 men and 13,394 women ages 25 to 75. Primary hyperparathyroidism, defined as a combination of serum calcium and parathyroid hormone (PTH) levels within the extreme or upper normal range, was diagnosed in 17 men and 47 women. The prevalence in both sexes increased with age. When 42 subjects with asymptomatic primary hyperparathyroidism were followed for 3 years, no significant increase in serum calcium or PTH was seen. In a subgroup of 473 men and 517 women ages 50 to 75, serum PTH was measured along with serum calcium. Depending on the criteria used to define primary hyperparathyroidism, the prevalence in older women within this subgroup ranged from 3.6% to 13.9%. The study concluded that a high prevalence of primary hyperparathyroidism exists in older women, although the progression of the disease, judging by serum calcium and PTH measurements, appears to be very slow.

Keywords:  Hypercalcaemia, Parathyroid hormone (PTH), Primary hyperparathyroidism (PHPT), Serum albumin, Serum calcium, PTH screening

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0895-4356(00)00239-0

Journal of Clinical Epidemiology
Volume 53, Issue 11 , Pages 1164-1169, November 2000